Workday 주식 가격. 1WDAY - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
이탈리아
BIT
Workday Inc (1WDAY) 시세

Workday Inc (1WDAY)

237.30

0.00

(0.00%)

마감 25 11월 1:30AM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

가격

237.30

매수가

257.85

매도가

258.35

거래량

0.00

0.00 일간 변동폭 0.00

188.58 52주 범위 284.55

market_cap

전일 종가

237.30

개장가

-

최근 거래 시간

마지막 거래 시간

재정 규모

-

VWAP

-

평균 볼륨(3m)

20

발행 주식

265,000,000

배당수익률

-

주가수익률

51.38

주당순이익(EPS)

5.21

매출

7.26B

순이익

1.38B

섹터

Cmp Processing,data Prep Svc

산업

Cmp Processing,data Prep Svc

웹사이트

www.workday.com

본부

Wilmington, Delaware, USA

설립됨

-

Workday Inc is listed in the Cmp Processing,data Prep Svc sector of the 이탈리아 증권거래소 with ticker 1WDAY. The last closing price for Workday was 237.30 €. Over the last year, Workday shares have traded in a share price range of 188.58 € to 284.55 €.

Workday currently has 265,000,000 shares in issue. The market capitalisation of Workday is 62.88 € billion. Workday has a price to earnings ratio (PE ratio) of 51.38.

No news to show yet.

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	DE
4	15.8	7.13318284424	221.5	239	213.75	15	234.0326087	DE
12	1.05	0.444444444444	236.25	239	213.75	20	228.53070539	DE
26	28.15	13.4592397801	209.15	239	188.58	25	213.6053074	DE
52	21.85	10.141564168	215.45	284.55	188.58	47	243.76458642	DE
156	21.85	10.141564168	215.45	284.55	188.58	47	243.76458642	DE
260	21.85	10.141564168	215.45	284.55	188.58	47	243.76458642	DE

가장 활성
% 상승자
% 패자

기호	가격	볼륨
WTFINTrevi Finanziaria Industriale Spa	1.30 € (28.71%)	31
PLCPlc Spa	1.775 € (18.73%)	167.84k
1SMCISuper Micro Computer Inc	31.53 € (16.35%)	28.42k
1MRNAModerna Inc	40.565 € (15.24%)	6.47k
COSMOFarmacosmo spa	0.43 € (12.86%)	93.07k
WISC24Integrated System Credit Consulting Fintech Spa	0.0035 € (-49.28%)	50k
ECNLAAAquafil SpA	0.039 € (-18.07%)	314.46k
1SYMSymrise AG	105.00 € (-17.13%)	62
WIVN26iVision Tech SpA	0.25 € (-16.67%)	6.51k
1EVTEvotec SE	8.26 € (-16.57%)	7.02k
TITTelecom Italia SpA	0.2317 € (0.78%)	106.93M
ISPIntesa Sanpaolo Spa	3.631 € (-1.00%)	95.09M
SPMSaipem Spa	2.399 € (1.18%)	56.12M
ENELEnel Spa	6.73 € (2.28%)	29.44M
RNRisanamento	0.0245 € (4.70%)	20.21M

1vman

1vman 4 분 전

***** No !!! 🚽UBQU🚽 Does not have 5 million in revenues , point in fact financials are not very good

ENOUGH SAID HUZZAH🤪 !!!

HoldEm777

HoldEm777 5 분 전

A bunch of koolaid being served Elks… Cheers.

BrownRickRoss

BrownRickRoss 5 분 전

Zorax

Zorax 6 분 전

Lets not forget that retard rand held up military promotions for what, at least two years?

alertmeipp

alertmeipp 7 분 전

Thanks for sharing your knowledge here. And to be fair, his term was clinical benefits not necessarily mean meeting primary endpoint in the study.

fuagf

fuagf 7 분 전

Anti-immigration voters loved it, but will Trump's backers allow him to crash the economy as much
as his promises would. It wouldn't be the first time Trump has lied himself into a position of power.

Hempy

Hempy 7 분 전

HoldEm777

HoldEm777 7 분 전

Must be a easy life for those peeps. Load when told to load and pump like hell and stick to the script regardless of how misleading it gets.

toohot

toohot 8 분 전

Patience is still the number one key here for BIEL. 2025 and beyond are going to be banner years. Yes!
‘Nuff said!!!

BUY $BIEL$

StayHumble

StayHumble 8 분 전

BUY low✅Sell HIGH✅$9.99 a Share wow🍀🍀✅✅

CrossFireTrader

CrossFireTrader 8 분 전

Well said, we're all good. Melvin has got this. Occasionally in business you hit little road blocks, Melvin has navigated this one with perfection. Patience good People...

alertmeipp

alertmeipp 9 분 전

Yes. Odd indeed, although iirc, they later found 935 failed the meet primary because healthy patients usually recovered themselves after day 2 anyways so adminstering them the drug after 48 hrs wasn’t useful … or something to that effect

if now even PED and high risk, which would have

dstock07734

dstock07734 9 분 전

Well, do all these cancers share the same type of immunosuppressive characteristics?

S3lfMade

S3lfMade 9 분 전

Been running since $1.40 with no pullback. Will likely consolidated back near $2 imo

mrkirby

mrkirby 9 분 전

You are so angry and so wrong. Sorry.

Viewmont

Viewmont 10 분 전

$CGAC Great future expected! https://x.com/artdigitalcorp

frrol

frrol 11 분 전

Wasn't aware of your private conversation. IR's "not sure" comment to you was silly and of no value. Trials are inherently unsure, such a comment is hindsight justification, and the company repeatedly asserted the Rett trial was "potentially pivotal". Keep the latter particularly in mind.

Thehubby

Thehubby 12 분 전

To use your movie analogy, if a director's first movie doesn't sell at the box office, will they get a second movie?
Further, it has been two years since our CEO declared that all endpoints on the AD trial were met, yet our PPS, and let's face it that's why we are here, is actually lower in

BIOChecker4

BIOChecker4 12 분 전

I read Hoskuld’s post that you were replying to. He was expressing an opinion about the trials. I guess if you define bashing as anything that doesn’t absolutely conform to the WGT preferred narrative, then I agree it was bashing.

I think most of the so-called bashers are people who

nyt

Thanks for posting that opinion. You've been dead wrong so far on all your others so you've made it easy to know the outcome will be the opposite of your call. Another pro vplm contrivance. Mark it.

ap17

ap17 13 분 전

It's envy for those not smart enough to buy in low and hold. That's how the less intelligent vent.

wallstreet1231

wallstreet1231 13 분 전

If you were a true investor, which you aren’t, you would be focusing on snpw itself - not third parties. You’ll learn.

All Wall Street frauds and "lawyer" Impersonators need to be exposed and that's exactly what I intend to keep doing.

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관